GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
BRENTFORD

Hellopages » Greater London » Hounslow » TW8 9GS

Company number 08283222
Status Active
Incorporation Date 6 November 2012
Company Type Private Limited Company
Address 980 GREAT WEST ROAD, BRENTFORD, MIDDLESEX, TW8 9GS
Home Country United Kingdom
Nature of Business 64209 - Activities of other holding companies n.e.c.
Phone, email, etc

Since the company registration fifteen events have happened. The last three records are Appointment of Kate Sophie Priestman as a director on 9 December 2016; Confirmation statement made on 6 November 2016 with updates; Termination of appointment of Fraser Gemmell Macfarlane as a director on 1 November 2016. The most likely internet sites of GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED are www.glaxosmithklineintellectualpropertydevelopment.co.uk, and www.glaxosmithkline-intellectual-property-development.co.uk. The predicted number of employees is 1 to 10. The company’s age is thirteen years and one months. Glaxosmithkline Intellectual Property Development Limited is a Private Limited Company. The company registration number is 08283222. Glaxosmithkline Intellectual Property Development Limited has been working since 06 November 2012. The present status of the company is Active. The registered address of Glaxosmithkline Intellectual Property Development Limited is 980 Great West Road Brentford Middlesex Tw8 9gs. . EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED is a Secretary of the company. DINGEMANS, Simon Paul is a Director of the company. LA CORTE, Luigi Felice is a Director of the company. PRIESTMAN, Kate Sophie is a Director of the company. WALKER, Adam is a Director of the company. EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED is a Director of the company. GLAXO GROUP LIMITED is a Director of the company. Director BLACKBURN, Paul Frederick has been resigned. Director MACFARLANE, Fraser Gemmell has been resigned. The company operates in "Activities of other holding companies n.e.c.".


Current Directors

Secretary
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED
Appointed Date: 06 November 2012

Director
DINGEMANS, Simon Paul
Appointed Date: 06 November 2012
62 years old

Director
LA CORTE, Luigi Felice
Appointed Date: 20 April 2015
55 years old

Director
PRIESTMAN, Kate Sophie
Appointed Date: 09 December 2016
52 years old

Director
WALKER, Adam
Appointed Date: 28 March 2013
58 years old

Director
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED
Appointed Date: 06 November 2012

Director
GLAXO GROUP LIMITED
Appointed Date: 06 November 2012

Resigned Directors

Director
BLACKBURN, Paul Frederick
Resigned: 01 February 2016
Appointed Date: 06 November 2012
71 years old

Director
MACFARLANE, Fraser Gemmell
Resigned: 01 November 2016
Appointed Date: 28 March 2013
54 years old

Persons With Significant Control

Glaxosmithkline Intellectual Property Mangement Limited
Notified on: 6 April 2016
Nature of control: Ownership of shares – 75% or more

GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED Events

07 Jan 2017
Appointment of Kate Sophie Priestman as a director on 9 December 2016
18 Nov 2016
Confirmation statement made on 6 November 2016 with updates
02 Nov 2016
Termination of appointment of Fraser Gemmell Macfarlane as a director on 1 November 2016
28 Sep 2016
Full accounts made up to 31 December 2015
08 Feb 2016
Termination of appointment of Paul Frederick Blackburn as a director on 1 February 2016
...
... and 5 more events
02 Jul 2014
Previous accounting period extended from 30 November 2013 to 31 December 2013
17 Dec 2013
Annual return made up to 6 November 2013 with full list of shareholders
Statement of capital on 2013-12-17
  • GBP 100

17 May 2013
Appointment of Dr Fraser Gemmell Macfarlane as a director
01 May 2013
Appointment of Adam Walker as a director
06 Nov 2012
Incorporation